Epithalon
A peptide studied in telomere and cellular-aging research, prescribed within a clinician-led healthy-aging plan built on your own labs.
- Studied in laboratory research on telomerase and cellular aging
- Explored in research on the pineal gland and daily rhythm
- Prescribed within a healthy-aging plan built on your labs
Individual results vary. Effects seen in cells have not been shown in people, and we make no lifespan claim.
- Live visit with a licensed clinician
- If prescribed, medication is included in the price and delivered to your home
- Subscription, cancel anytime
Indicative price · confirmed after eligibility · prescription treatment
What Epithalon is
Epithalon is a synthetic tetrapeptide, four amino acids (alanine-glutamate-aspartate-glycine), developed from a line of research into peptides from the pineal gland. You will also see it written Epitalon, including in the FDA's own record. Same substance, two transliterations.
Most people come to Epithalon through the telomere story. Telomeres are the protective caps at the ends of chromosomes, and telomerase is the enzyme that maintains them. Laboratory work by the group that developed Epithalon reported telomerase activity and telomere elongation in cultured human cells, which is why it sits at the center of so much longevity interest. The telomere claim, examined covers that research in depth.
At ACT 2, Epithalon is prescribed within a healthy-aging plan built on the measurements that matter now, including blood pressure, ApoB, glucose regulation, muscle and sleep, with a clinician reviewing it at follow-up.
Epithalon, also spelled epitalon, is a short synthetic peptide derived from epithalamin, a pineal-gland extract studied from the 1980s onward. It is best known for laboratory research on telomerase, the enzyme that maintains the protective caps at the ends of chromosomes, and is explored in the context of cellular aging. It is not FDA-approved; it is prepared by a licensed compounding pharmacy under an individual prescription.
How it works here
Every plan follows one path. Each step feeds the next. See the Peptide Therapy approach.
- 01
Measure
We baseline your labs, history, and goals.
- 02
Plan
A clinician decides whether this fits — and what else might serve you.
- 03
Act
If appropriate, you start with clear guidance and high-touch support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
Where the research comes from
Most of what is known about Epithalon traces back to a research program in St Petersburg, led by Vladimir Khavinson and colleagues from the Soviet period onward.
It began with epithalamin, an extract of bovine pineal gland, studied on the premise that the pineal gland regulates biological rhythm and that its output falls with age. Epithalon is the synthetic successor: a defined four-amino-acid sequence designed to reproduce that activity consistently.
The evidence base works through what the underlying studies did, including how the human cohort reports were designed.
Why people choose Epithalon
Epithalon draws people for a few distinct reasons. Here is how each lines up with the research.
Epithalon is explored within healthy-aging research. We make no lifespan or anti-aging claim, and your plan is built around markers you can measure.
Safety and eligibility
Telomerase activity is also a feature of many cancers. That does not make Epithalon a carcinogen, and some of the originating group's animal work reported the opposite of what you might fear, but it is why a personal history of cancer is reviewed carefully before anything is prescribed.
Long-term safety in people has not been studied, so your history and medications are reviewed at assessment and you are followed up while you are on it.
What the program includes
Every Epithalon prescription at ACT 2 comes with the same clinical structure:
Clinician-led assessment and prescription. A licensed clinician reviews your history, goals and current medications, and prescribes only when it is appropriate for you.
A licensed U.S. compounding pharmacy. Your prescription is prepared individually for you by a licensed U.S. compounding pharmacy.
Baseline labs and monitoring. A Comprehensive Lab Panel before you start, and the relevant markers rechecked as you go.
A published monthly price. What you pay is on the pricing page before you book, with no hidden consult charge.
Follow-up and adjustment. Your clinician reviews progress against the goals you agreed at the start and adjusts the plan, including when to pause or stop.
No membership fee. There is no fee to be assessed, and you pay for treatment only if it is prescribed and you choose to go ahead.
How it works at ACT 2
A compounded preparation, dispensed by a licensed pharmacy on an individual prescription. How it is taken is set by the prescribing clinician after a review.
Who it's for
Adults over 45 who take healthy aging seriously and want the cellular-aging research brought into a measured, clinician-led plan. It starts with a baseline panel, because what you can act on today shows up there. A personal history of cancer is reviewed carefully at your assessment. See peptide therapy.
A healthy-aging plan built on your numbers
The markers that track most closely with how the next twenty years go show up on a baseline panel and a cardiovascular risk workup: blood pressure, ApoB, glucose regulation, muscle mass, sleep, alcohol, and whether you are up to date on the cancer screening your age and history call for.
Your plan starts there. Where Epithalon fits, your clinician prescribes it as one part of that plan and reviews it at follow-up. Peptide therapy covers how the category is handled here, and pricing is on the pricing page.
Clinicians who focus on longevity
Your visit is with a licensed clinician in your state. These are the members of the medical team whose practice centers on longevity; who you see depends on your state and availability.
Medical services are provided by licensed clinicians practicing through an independent professional entity.
Often considered alongside
MOTS-c
CompoundedA peptide encoded in your mitochondria, studied for cellular energy and metabolism, prescribed within a clinician-led plan built on your labs.
View treatmentNAD+ Injection
CompoundedA coenzyme central to cellular energy, explored to support energy and recovery in midlife.
View treatmentRapamycin
An mTOR inhibitor studied in longevity research, considered under close clinical oversight.
View treatmentProducts marked Compounded are prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved and are not equivalent to or interchangeable with any branded product.
Epithalon, question by question
The specific questions people bring to this treatment, each answered on its own page and reviewed the same way this one is.
Epithalon and Telomerase: The Claims Examined
Epithalon is sold on telomerase and telomere length. Where those claims come from, what a cell marker can and cannot tell you, and what it does not say.
ReadEpithalon Evidence: What the Research Shows
Most Epithalon research is one Russian program running since the 1980s, from a pineal extract. What it reported, and why replication is the missing piece.
Read
What the research shows
Most Epithalon research comes from one research program and its collaborators, much of it in cells and animals, with human cohort reports from the same group and no independent controlled trial; long-term safety in people has not been studied. The telomerase findings are laboratory results, not a demonstrated effect on human health or lifespan. It is not FDA-approved; it is prepared by a licensed compounding pharmacy under an individual prescription. On regulation: in April 2026 the FDA removed twelve peptide substances, Epitalon among them, from Category 2 of its interim 503A bulk substances list after the nominations were withdrawn. That was not a safety finding, and it did not by itself authorize compounding. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted to recommend Epitalon for the 503A Bulks List. Committee votes are advisory: formal addition to the list requires notice-and-comment rulemaking, which had not completed as of September 2026.
References
Government and professional-society sources consulted for this page.
- FDA Briefing Document for Epitalon-Related Bulk Drug Substances, Pharmacy Compounding Advisory Committee, July 23-24, 2026 — U.S. Food and Drug Administration (2026)
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks — U.S. Food and Drug Administration
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act — U.S. Food and Drug Administration
Frequently asked questions
No one can tell you that, and we do not make that claim. Epithalon is studied in cellular-aging research; the telomere claim, examined explains where that research comes from and where it stands.
Yes, the two spellings refer to the same compound.
Largely from Russian research on epithalamin and the pineal gland from the 1980s onward. The evidence base covers it in detail.
Not because of where it was done. What the field is waiting for is independent replication and controlled human trials, which would matter just as much for single-source research from anywhere.
A change in cells in a laboratory is a strong reason for research interest, not evidence of benefit in a person. Telomerase is also active in many cancers, which is why your history is reviewed before anything is prescribed.
No. Commercial telomere-length tests have poor reproducibility and no established use in guiding individual care. A baseline panel tells you things you can act on.
No. It is not FDA-approved for any use. It is prepared by a licensed compounding pharmacy under an individual prescription. The FDA advisory committee's July 2026 recommendation concerned eligibility for compounding, not approval, and takes effect only through rulemaking.
Because people ask for it, and the right way to use it is within a clinician-led plan with labs and follow-up, not from a research-chemical website.
See if Epithalon fits your plan
The right plan begins with knowing where you are. Start with a short eligibility check and a baseline — and we'll tell you, honestly, what fits.
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.